Kenneth Zuerblis

This profile gathers the share dealings of Kenneth Zuerblis in Zenith Epigenetics Corp. In total, 4 filings cover trades dated from 3 June 2013 to 6 June 2016.

The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

Most recently, on 8 June 2016, the filings show a transaction in Zenith Epigenetics Corp. The median gap between a trade and its publication by SEDI is 5 days. That lag is the time during which only the insider knows about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.